Gilead Sciences | 债务

Debt 更改 日
AbbVie USD 60.75B 269M 2023-09
Agios Pharmaceuticals USD 1.14M 84K 2022-09
ALKERMES USD 291.37M 635K 2023-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 64.61B 4.15B 2023-12
Eli Lilly USD 20.17B 1.35B 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Incyte USD 32.6M 678K 2023-12
Moderna USD 575M 150M 2023-12
Neurocrine Biosciences USD 169.9M 200K 2023-09
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
United Therapeutics USD 700M 100M 2023-12
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Gilead Sciences 债务 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.